elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42
Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42
Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
P2860
Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1a994dba5101d7a97aad2d78b70b1e093eadc3c
P2860
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.